You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

CLINICAL TRIALS PROFILE FOR TAFAMIDIS MEGLUMINE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for TAFAMIDIS MEGLUMINE

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01435655 ↗	The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin	Completed	Pfizer	Phase 3	2011-11-01	Tafamidis has been developed as an oral specific stabilizer of transthyretin tetramer.
NCT01994889 ↗	Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy	Completed	Pfizer	Phase 3	2013-12-09	This Phase 3 study will investigate the efficacy, safety and tolerability of an oral daily dose of 20 mg or 80 mg tafamidis meglumine capsules compared to placebo in subjects with either transthyretin genetic variants or wild-type transthyretin resulting in amyloid cardiomyopathy.
NCT02791230 ↗	Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy	Active, not recruiting	Pfizer	Phase 3	2016-06-13	Open label study to evaluate tafamidis for the treatment of transthyretin cardiomyopathy
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for TAFAMIDIS MEGLUMINE

Condition Name

Chart
Table

Condition Name for TAFAMIDIS MEGLUMINE
Intervention	Trials
Healthy	4
Transthyretin (TTR) Amyloid Cardiomyopathy	2
Healthy Volunteers	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for TAFAMIDIS MEGLUMINE
Intervention	Trials
Amyloidosis	4
Amyloid Neuropathies	2
Cardiomyopathies	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for TAFAMIDIS MEGLUMINE

Trials by Country

Map
Table

Trials by Country for TAFAMIDIS MEGLUMINE
Location	Trials
United States	39
Japan	8
Canada	6
China	5
Spain	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for TAFAMIDIS MEGLUMINE
Location	Trials
Alabama	2
Michigan	2
California	2
Florida	2
Illinois	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for TAFAMIDIS MEGLUMINE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for TAFAMIDIS MEGLUMINE
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	3
Phase 1	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for TAFAMIDIS MEGLUMINE
Clinical Trial Phase	Trials
Completed	6
Recruiting	1
Active, not recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TAFAMIDIS MEGLUMINE

Sponsor Name

Chart
Table

Sponsor Name for TAFAMIDIS MEGLUMINE
Sponsor	Trials
Pfizer	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for TAFAMIDIS MEGLUMINE
Sponsor	Trials
Industry	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.